Press Release: Joni Ernst Advances Legislation to Enhance American Manufacturing and Combat COVID-19 Fraud

The U.S. Senate Committee on Small Business and Entrepreneurship has advanced two key bills proposed by Senator Joni Ernst: the *Made in America Manufacturing Finance Act* and the *SBA Fraud Enforcement Extension Act*. The former aims to double loan limits for small manufacturers, potentially bolstering domestic production capabilities, while the latter extends the statute of limitations for prosecuting COVID-19 related fraud, signaling increased accountability for misuse of pandemic relief funds. These legislative advancements could impact financing access for small businesses and enhance oversight of government aid programs.

Analysis

Two legislative proposals by Senator Joni Ernst have advanced in the U.S. Senate Committee on Small Business and Entrepreneurship, signaling a dual focus on bolstering domestic manufacturing and enforcing fiscal accountability. The first bill, the *Made in America Manufacturing Finance Act*, aims to double loan limits for small manufacturers, a move intended to directly improve access to capital and stimulate domestic production. While the market impact is currently assessed as low, its passage could provide a tailwind for the U.S. small-to-medium enterprise (SME) manufacturing base. The second bill, the *SBA Fraud Enforcement Extension Act*, extends the statute of limitations for prosecuting COVID-19 relief fraud. This reflects a continued political and legal emphasis on recovering misappropriated funds and suggests that legal and litigation risks may persist for entities that received pandemic aid. The advancement of these bills, while still an early legislative step, points to policy momentum in the areas of industrial policy and post-pandemic fiscal oversight.

Key Decisions for Investors

• Investors with exposure to the small-cap industrial sector or regional banks specializing in SBA loans should monitor the progress of the *Made in America Manufacturing Finance Act*, as its enactment could improve credit availability and growth prospects for this segment.
• Consider identifying publicly-traded suppliers of raw materials, machinery, and software to small manufacturers, as these companies could be indirect beneficiaries if the bill successfully channels more capital into domestic production.
• The focus on extending the statute of limitations for pandemic fraud reinforces the theme of regulatory and legal scrutiny; investors should remain cautious about companies that have previously faced questions regarding their use of COVID-19 relief funds.